CDMRP Supports Critical Developments in ALS, a...
Since fiscal year 2007, the Amyotrophic Lateral Sclerosis Research Program received $309.4 million in congressional appropriations, including $40 million in fiscal year 2025, to support research to find new treatments and cures for ALS.
Research funded by the ALSRP led to experimental treatments, new biomarkers, and devices advancing through clinical trials or in development with industry partners.